diazepam has been researched along with Agoraphobia in 25 studies
Diazepam: A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity.
diazepam : A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one substituted by a chloro group at position 7, a methyl group at position 1 and a phenyl group at position 5.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty out-patients suffering from panic disorders associated with agoraphobia were enrolled in a double-blind, controlled trial to compare the effectiveness and tolerability of etizolam and placebo." | 9.06 | Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study. ( Ecari, U; Savoldi, F; Somenzini, G, 1990) |
| "The response to diazepam and propranolol hydrochloride was compared in 21 patients who (with one exception) met DSM-III criteria for panic disorder and agoraphobia." | 9.05 | Diazepam and propranolol in panic disorder and agoraphobia. ( Anderson, DJ; Clancy, J; Crowe, RR; Ghoneim, MM; Hinrichs, JV; Noyes, R; Slymen, DJ, 1984) |
| "A multi-centre, double-blind trial was carried out in general practice to compare the effectiveness and tolerability of clomipramine and diazepam in patients with agoraphobia or social phobia." | 9.05 | Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice. ( Allsopp, LF; Cooper, GL; Poole, PH, 1984) |
| "The effects of oral doses of diazepam (single dose of 10 mg and a median dose of 30 mg/day for 2 weeks) and propranolol (single dose of 80 mg and a median dose of 240 mg/day for 2 weeks) on psychological performance of patients with panic disorders and agoraphobia were investigated in a double-blind, randomized and crossover design." | 9.05 | Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia. ( Anderson, DJ; Ghoneim, MM; Hinrichs, JV; Noyes, R, 1984) |
| "Fifty-seven chronic agoraphobic outpatients were treated by 12 hours of exposure in vivo on four days over two weeks to check the effects of oral diazepam versus placebo during group exposure, group versus individual exposure, and high versus medium anxiety arousal during individual exposure." | 9.04 | Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation. ( Hafner, J; Marks, I, 1976) |
| "Thirty out-patients suffering from panic disorders associated with agoraphobia were enrolled in a double-blind, controlled trial to compare the effectiveness and tolerability of etizolam and placebo." | 5.06 | Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study. ( Ecari, U; Savoldi, F; Somenzini, G, 1990) |
| "The response to diazepam and propranolol hydrochloride was compared in 21 patients who (with one exception) met DSM-III criteria for panic disorder and agoraphobia." | 5.05 | Diazepam and propranolol in panic disorder and agoraphobia. ( Anderson, DJ; Clancy, J; Crowe, RR; Ghoneim, MM; Hinrichs, JV; Noyes, R; Slymen, DJ, 1984) |
| "Thirty-six patients with generalised anxiety disorder, panic disorder or agoraphobia with panic attacks, diagnosed by DSM-III criteria, were treated with a new non-benzodiazepine anti-anxiety drug, buspirone, and with diazepam and placebo, in a cross-over design." | 5.05 | Anxiety in primary care: is short-term drug treatment appropriate? ( Owen, R; Tyrer, P, 1984) |
| "A multi-centre, double-blind trial was carried out in general practice to compare the effectiveness and tolerability of clomipramine and diazepam in patients with agoraphobia or social phobia." | 5.05 | Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice. ( Allsopp, LF; Cooper, GL; Poole, PH, 1984) |
| "The effects of oral doses of diazepam (single dose of 10 mg and a median dose of 30 mg/day for 2 weeks) and propranolol (single dose of 80 mg and a median dose of 240 mg/day for 2 weeks) on psychological performance of patients with panic disorders and agoraphobia were investigated in a double-blind, randomized and crossover design." | 5.05 | Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia. ( Anderson, DJ; Ghoneim, MM; Hinrichs, JV; Noyes, R, 1984) |
| "Fifty-seven chronic agoraphobic outpatients were treated by 12 hours of exposure in vivo on four days over two weeks to check the effects of oral diazepam versus placebo during group exposure, group versus individual exposure, and high versus medium anxiety arousal during individual exposure." | 5.04 | Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation. ( Hafner, J; Marks, I, 1976) |
| " Self-ratings of avoidance and distress, frequency of panic attacks, diazepam use, and negative cognitions decreased with treatment." | 3.68 | Cognitive-behavioral treatment for panic disorder with gastrointestinal symptoms: a case study. ( Eldridge, GD; Holborn, SW; Walker, JR, 1993) |
| "The diazepam pretreatment condition was associated with a significantly increased infusion duration and a significant attenuation of rate of API symptom increase in response to lactate." | 2.68 | Effects of intravenous diazepam pretreatment on lactate-induced panic. ( Campeas, RB; Coplan, JD; Davies, SO; Dillon, DJ; Fyer, AJ; Gorman, JM; Klein, DF; Liebowitz, MR; Martinez, J, 1995) |
| "The greatest problem with combined treatment is relapse after drug discontinuance." | 2.40 | Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials. ( Bruce, TJ; Spiegel, DA, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (60.00) | 18.7374 |
| 1990's | 9 (36.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gruber, EN | 1 |
| Dordević, V | 1 |
| Biocina-Martić, S | 1 |
| Agius, M | 1 |
| Marks, I | 2 |
| Noyes, R | 4 |
| Anderson, DJ | 2 |
| Clancy, J | 1 |
| Crowe, RR | 1 |
| Slymen, DJ | 1 |
| Ghoneim, MM | 2 |
| Hinrichs, JV | 2 |
| Tyrer, P | 1 |
| Owen, R | 1 |
| Allsopp, LF | 1 |
| Cooper, GL | 1 |
| Poole, PH | 1 |
| Davis, JM | 1 |
| Nasr, S | 1 |
| Spira, N | 1 |
| Vogel, C | 1 |
| Pohl, R | 2 |
| Berchou, R | 1 |
| Rainey, JM | 1 |
| Wardle, J | 2 |
| Hayward, P | 2 |
| Higgitt, A | 2 |
| Stabl, M | 1 |
| Blizard, R | 1 |
| Gray, J | 2 |
| Eldridge, GD | 1 |
| Walker, JR | 1 |
| Holborn, SW | 1 |
| Balon, R | 1 |
| Yeragani, VK | 1 |
| Merlos, B | 1 |
| Sherwood, P | 1 |
| Liebowitz, MR | 1 |
| Coplan, JD | 1 |
| Martinez, J | 1 |
| Fyer, AJ | 1 |
| Dillon, DJ | 1 |
| Campeas, RB | 1 |
| Davies, SO | 1 |
| Gorman, JM | 1 |
| Klein, DF | 1 |
| Spiegel, DA | 1 |
| Bruce, TJ | 1 |
| Hafner, J | 1 |
| Hafner, RJ | 1 |
| Mountjoy, CQ | 1 |
| Roth, M | 1 |
| Garside, RF | 1 |
| Leitch, IM | 1 |
| McElroy, SL | 1 |
| Keck, PE | 1 |
| Lawrence, JM | 1 |
| Savoldi, F | 1 |
| Somenzini, G | 1 |
| Ecari, U | 1 |
| Lopez, AL | 1 |
| Kathol, RG | 1 |
| Lilienfeld, SO | 1 |
| Jacob, RG | 1 |
| Furman, JM | 1 |
| Dager, SR | 1 |
| Cowley, DS | 1 |
| Dunner, DL | 1 |
| Coryell, W | 1 |
| Lutz, EG | 1 |
| Lutz, MB | 1 |
| Lutz, GE | 1 |
| Finkel, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of Pre- and Post-Synaptic Dopamine Function in Developmental Stuttering Using 11C-Raclopride and Positron Emission Tomography[NCT00024960] | 12 participants (Actual) | Observational | 2001-10-03 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for diazepam and Agoraphobia
| Article | Year |
|---|---|
Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials.
Topics: Agoraphobia; Animals; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combi | 1997 |
15 trials available for diazepam and Agoraphobia
| Article | Year |
|---|---|
Comparative studies on benzodiazepines and psychotherapies.
Topics: Agoraphobia; Anxiety; Clinical Trials as Topic; Diazepam; Double-Blind Method; Humans; Palliative Ca | 1983 |
Diazepam and propranolol in panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Depression; Diazepam; Double-Blind | 1984 |
Anxiety in primary care: is short-term drug treatment appropriate?
Topics: Adult; Agoraphobia; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Diazepam; Female; Humans | 1984 |
Clomipramine and diazepam in the treatment of agoraphobia and social phobia in general practice.
Topics: Adolescent; Adult; Aged; Agoraphobia; Clinical Trials as Topic; Clomipramine; Diazepam; Double-Blind | 1984 |
Behavioral effects of diazepam and propranolol in patients with panic disorder and agoraphobia.
Topics: Adult; Agoraphobia; Clinical Trials as Topic; Cognition; Diazepam; Double-Blind Method; Fear; Female | 1984 |
Anxiety: differential diagnosis and treatment from a biologic perspective.
Topics: Agoraphobia; Anxiety Disorders; Clinical Trials as Topic; Diagnosis, Differential; Diazepam; Double- | 1981 |
Effects of concurrent diazepam treatment on the outcome of exposure therapy in agoraphobia.
Topics: Adult; Agoraphobia; Combined Modality Therapy; Desensitization, Psychologic; Diazepam; Dose-Response | 1994 |
Changes in appetite and weight during the pharmacological treatment of patients with panic disorder.
Topics: Adult; Agoraphobia; Appetite; Body Weight; Diazepam; Dietary Carbohydrates; Double-Blind Method; Fem | 1993 |
Effects of intravenous diazepam pretreatment on lactate-induced panic.
Topics: Adult; Agoraphobia; Anti-Anxiety Agents; Arousal; Blood Pressure; Diazepam; Fear; Female; Heart Rate | 1995 |
Changes in "withdrawal symptoms" following discontinuation of low-dose diazepam.
Topics: Adult; Agoraphobia; Anti-Anxiety Agents; Anxiety Disorders; Diazepam; Double-Blind Method; Female; H | 1996 |
Exposure in vivo of agoraphobics: contributions of diazepam, group exposure, and anxiety evocation.
Topics: Administration, Oral; Agoraphobia; Anxiety; Behavior Therapy; Chronic Disease; Desensitization, Psyc | 1976 |
A clinical trial of phenelzine in anxiety depressive and phobic neuroses.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Agoraphobia; Anxiety Disorders; Clinical Trials as To | 1977 |
Etizolam versus placebo in the treatment of panic disorder with agoraphobia: a double-blind study.
Topics: Adult; Agoraphobia; Chronic Disease; Diazepam; Double-Blind Method; Drug Administration Schedule; Fe | 1990 |
Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Benzodiazepines; Depression; Diazepam; Fear; Female; Humans; Hydroco | 1990 |
Placebo response in panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anxiety Disorders; Clinical Trials as Topic; Dexamethasone; Diazepam | 1988 |
9 other studies available for diazepam and Agoraphobia
| Article | Year |
|---|---|
"My new Alfa Romeo GT is not in the garage any more": Cognitive behavioural therapy of panic disorder with agoraphobia co morbid with psychosis.
Topics: Adult; Agoraphobia; Antipsychotic Agents; Atenolol; Benzodiazepines; Cognitive Behavioral Therapy; C | 2006 |
Tricyclic antidepressants and monoamine oxidase inhibitors in the treatment of agoraphobia.
Topics: Agoraphobia; Antidepressive Agents, Tricyclic; Clomipramine; Diazepam; Double-Blind Method; Humans; | 1982 |
Cognitive-behavioral treatment for panic disorder with gastrointestinal symptoms: a case study.
Topics: Adult; Agoraphobia; Behavior Therapy; Diazepam; Fecal Incontinence; Female; Humans; Panic Disorder | 1993 |
Fresh symptom emergence after intensive behaviour therapy.
Topics: Agoraphobia; Behavior Therapy; Desensitization, Psychologic; Diazepam; Evaluation Studies as Topic; | 1976 |
Treatment of panic disorder and benzodiazepine withdrawal with valproate.
Topics: Adult; Agoraphobia; Clonazepam; Diazepam; Dose-Response Relationship, Drug; Humans; Male; Panic Diso | 1991 |
Vestibular dysfunction followed by panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Avoidance Learning; Diazepam; Fear; Humans; Male; Panic; Vestibular Diseases | 1989 |
Biological markers in panic states: lactate-induced panic and mitral valve prolapse.
Topics: Adolescent; Adult; Aged; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Creatinine | 1987 |
Agoraphobia and paroxysmal cerebral dysrhythmia.
Topics: Agoraphobia; Diazepam; Electroencephalography; Epilepsy; Humans; Phobic Disorders | 1987 |
Diazepam in a patient with chronic schizophrenia complicated by agoraphobia.
Topics: Adult; Agoraphobia; Behavior Therapy; Combined Modality Therapy; Diazepam; Humans; Male; Phobic Diso | 1987 |